title: Bone mineral density improvement in spondyloarthropathy after treatment with etanercept.
authors.forename: H
authors.initials: H
authors.lastname: Marzo-Ortega
authors.forename: D
authors.initials: D
authors.lastname: McGonagle
authors.forename: G
authors.initials: G
authors.lastname: Haugeberg
authors.forename: M J
authors.initials: MJ
authors.lastname: Green
authors.forename: S P
authors.initials: SP
authors.lastname: Stewart
authors.forename: P
authors.initials: P
authors.lastname: Emery
mesh_terms: D000328:Adult; D015519:Bone Density / Q000187:drug effects*; D000068800:Etanercept; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D025242:Spondylarthropathies / Q000188:drug therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept